Navigation Links
New peptide communication factor enabling bacteria to 'talk to each other' discovered
Date:10/29/2007

Jerusalem Discovery by Hebrew University of Jerusalem researchers of a new communication factor that enables bacteria to talk to each other and causes their death could have significant consequences leading to development of a new class of antibiotic medications.

Bacteria are traditionally considered unicellular organisms. However, increasing experimental evidence indicates that bacteria seldom behave as isolated organisms. Instead, they are members of a community in which the isolated organisms communicate among themselves, thereby manifesting some multi-cellular behaviors.

In an article published Friday (Oct. 26) in the journal Science, the Hebrew University scientists describe the new communication factor they have discovered that is produced by the intestinal bacteria Escherichia coli. The new factor is secreted by the bacteria and serves as a communication signal between single bacterial cells.

The research was carried out by a group headed by Prof. Hanna Engelberg-Kulka of the Department of Molecular Biology at the Hebrew University Hadassah Medical School. It includes Ph.D. student Ilana Kolodkin-Gal , and a previous Ph.D. student, Dr Ronen Hazan. In addition, the research included Dr Ariel Gaathon from the Facilities Unit of the Medical School.

The communication factor formed by Escherichia coli enables the activation of a built-in suicide module which is located on the bacterial chromosome and is esponsible for bacterial cell death under stressful conditions. Therefore, the new factor has been designated EDF (Extra-cellular Death Factor).

While suicidal cell death is counterproductive for the individual bacterial cell, it becomes effective for the bacterial community as a whole by the simultaneous action of a group of cells that are signaled by EDF. Under stressful conditions in which the EDF is activated, a major sub-population within the bacterial culture dies, allowing the survival of the population as a whole.

Understanding how the EDF functions may provide a lead for a new and more efficient class of antibiotics that specifically trigger bacterial cell death in the intestine bacteria Escherichia coli and probably in many other bacteria, including those pathogens that also carry the suicide module.

The discovered communication factor is a novel biological molecule, noted Prof Engelberg-Kulka. It is a peptide (a very small protein) that is produced by the bacteria. The chemical characterization of the new communication factor was particularly difficult for the researchers because of two main reasons: it is present in the bacterial culture in minute amounts, and the factor decomposes under the conditions that are routinely used during standard chemical characterization methods. Therefore, it was necessary to develop a new specific method. The research has also identified several bacterial genes that are involved in the generation of the communication factor, said Prof. Engelberg-Kulka. .


'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem  
Source:Eurekalert

Related medicine news :

1. New Insight To The Role Of Peptide Signals
2. Biocon to colloborate for development of Oral peptide drugs for heart diseases.
3. Discovery of Elevated Amyloid Peptide levels could lead to Alzheimer’s Preventio
4. Peptide Found in Human Blood Inhibits 60 Strains of HIV, Study Says
5. Stress Protein Inactivation Cuts Alzheimers Peptide in Mice
6. Specific Imbalance Between Two Peptides may Cause Alzheimers
7. Appetite-regulating Peptides Influence Alcohol Cravings
8. Improved parent-physician communication to prevent hospitalizations for childhood asthma
9. Physician and Patient relationship strained due to non-verbal communications
10. Better Communication With FDA Could Speed Up Approval Of New Drugs
11. Doctoral communication gets wired badge: wireless communication.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New peptide communication factor enabling bacteria to 'talk to each other' discovered
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: